Athira Pharma, Inc. (ATHA)
$4.79+1.48%Close
SELLCRISIS · day 15
Key stats
- Market cap
- $19M
- Avg volume
- 1.1M
- Beta
- 2.80
- P/E (TTM)
- -0.24
- 1W
- +1.70%
- 1M
- -31.08%
- 3M
- +11.92%
- YTD
- -31.18%
- vs SPY 1W
- +2.89%
- vs SPY 1M
- -34.40%
- vs SPY 3M
- +9.52%
- vs SPY YTD
- -42.93%
Sector peers
Same-sector names ranked by LOPJLB quality proximity · Healthcare
- CARLBUYCarlsmed, Inc.RECOVERYQ 17$15.80-1.56%
- SGMTBUYSagimet Biosciences Inc.BULLQ 8$10.21-0.39%
- TARASELLProtara Therapeutics, Inc.RECOVERYQ -19$3.87+0.52%
- AMNBUYAMN Healthcare Services, Inc.BULLQ 5$34.51+0.15%
- CARMSELLCarisma Therapeutics, Inc.CRISISQ -12$0.00
- RADXSELLRadiopharm Theranostics LimitedCRISISQ -20$2.44+0.00%
- SABSBUYSAB Biotherapeutics, Inc.RECOVERYQ -11$3.62-4.23%
- CADLBUYCandel Therapeutics, Inc.BULLQ 22$12.86-2.06%
- BLSMFLATBlossomHill Therapeutics, Inc.Q 16$16.03-2.14%
- ACBBUYAurora Cannabis Inc.RECOVERYQ 0$3.94+0.00%
- CMNDBUYClearmind Medicine Inc.CRISISQ -23$1.68-3.45%
- NTHIBUYNeonc Technologies Holdings, Inc.CRISISQ -14$4.69+0.21%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 16
- VALUE
- 32
- GROWTH
- 47
- GARP
- 6
- TYPE
- Value / Recovery
Composite of Value · Growth · GARP
ROIC-246.9%
REV YoY-
ROE-411.6%
EPS YoY-
ROA-248.6%
GROSS0
OP0
NET0
[VALUATION]
P/E TTM-0.24
P/E FWD-
SECTOR PE22.57
INDUSTRY PE17.06
P/B0.99
P/FCF-
EV/EBITDA0.01
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E1.72
ALTMAN Z-
CURR RATIO7.01
ND/EBITDA-
BETA2.80













